Post-translational Modifications of Recombinant Proteins: Significance for Biopharmaceuticals

Nigel Jenkins, Lisa Murphy, Ray Tyther

DOI: 10.1007/s12033-008-9049-4
Referenced 116 times
Share this paper
Use this link to share this page publicly